A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection. (2018)
Attributed to:
Immunity in the face of diversity and the development of novel potent HCV vaccines
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2018.03175
PubMed Identifier: 30713538
Publication URI: http://europepmc.org/abstract/MED/30713538
Type: Journal Article/Review
Volume: 9
Parent Publication: Frontiers in immunology
ISSN: 1664-3224